M&A Deal Summary

Galderma Acquires CollaGenex Pharmaceuticals

On April 10, 2008, Galderma acquired life science company CollaGenex Pharmaceuticals from Aisling Capital and Oaktree Capital Management for 420M USD

Acquisition Highlights
  • This is Galderma’s 1st transaction in the Life Science sector.
  • This is Galderma’s largest (disclosed) transaction.
  • This is Galderma’s 1st transaction in the United States.
  • This is Galderma’s 1st transaction in Pennsylvania.

M&A Deal Summary
Date 2008-04-10
Target CollaGenex Pharmaceuticals
Sector Life Science
Buyer(s) Galderma
Sellers(s) Aisling Capital
Oaktree Capital Management
Deal Type Add-on Acquisition
Deal Value 420M USD

Target

CollaGenex Pharmaceuticals

Newtown, Pennsylvania, United States
website
CollaGenex Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the dental and dermatology markets.

Search 193,724 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Galderma

Zug, Switzerland

website

Category Company
Founded 1981
Sector Healthcare Services
Revenue 2.8B CHF (2018)
DESCRIPTION

Galderma is a global skincare company offering a range of medical and consumer skin health solutions through three business units; aesthetics and prescription and consumer health. Galderma was founded in 1981 and is based in Zug, Switzerland.

DEAL STATS #
Overall 1 of 2
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 2
State (Pennsylvania) 1 of 1
Country (United States) 1 of 1
Year (2008) 1 of 1
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-12-12 Spirig Pharma AG

Egerkingen, Switzerland

Spirig Pharma AG engages in the development, production, and marketing of dermatological and dermacosmetic products with over 60 years of experience. Spirig also has distribution partners in 15 markets. Spirig Pharma AG provides exceptional products and services to dermatologists, general practitioners, drug stores, and pharmacies. Its well-known brands include Daylong for sun protection and Excipial for the care of dry, sensitive skin.

Buy -

Seller(S) 2

SELLER

Aisling Capital

New York, New York, United States

Investor Investor Investor Investor Investor

website

Category Private Equity Firm
Founded 2000
PE ASSETS 1.8B USD
Size Large
Type Sector Focused
DESCRIPTION

Aisling Capital is a private investment firm focused on opportunities in the healthcare and medical technology sectors. The Firm specifically looks to invest in companies developing and commercializing innovative healthcare products, services, and technologies. Aisling Capital looks to commit $20 to $50 million per investment and prefers to be the lead investor. Aisling will consider investing in both public and private companies. Aisling Capital raised its first fund in 2000. The Firm is based in New York City.

DEAL STATS #
Overall 8 of 41
Sector (Life Science) 8 of 32
Type (Add-on Acquisition) 7 of 24
State (Pennsylvania) 1 of 3
Country (United States) 8 of 41
Year (2008) 2 of 4
Size (of disclosed) 5 of 12
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-03-12 Advion

Ithaca, New York, United States

Advion is a leading provider of bioanalytical services to the pharmaceutical industry, and a developer of automated, chip-based technology designed to boost the sensitivity, data quality and sample throughput for electrospray mass spectrometers

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-06-01 Interpharm Holdings

Hauppauge, New York, United States

Manufacturer of generic OTC and prescription pharmaceuticals

Sell -
SELLER

Oaktree Capital Management

Investor Investor Investor Investor Investor

website

Category Asset Manager
Founded 1995
Size Mega
Type Sector Agnostic
DESCRIPTION

Oaktree Capital Management LLP is a global alternative investment firm with a variety of investment strategies spanning corporate debt, convertible securities, distressed debt, control investing, real estate, and public investing. The Firm's control investing group is spread across several disciplines, including Global Principal, European Principal, Power, and Infrastructure. Oaktree was formed in 1995 and is based in Los Angeles.

DEAL STATS #
Overall 25 of 74
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 16 of 30
State (Pennsylvania) 2 of 4
Country (United States) 21 of 53
Year (2008) 3 of 4
Size (of disclosed) 7 of 17
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-01-01 Stock Polska sp. z o.o.

Warsaw, Poland

Stock Polska sp. z o.o. is a beverages company.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-06-02 Tekni-Plex

Wayne, Pennsylvania, United States

Tekni-Plex is a globally-integrated company focused on developing and manufacturing innovative packaging materials, medical compounds and precision-crafted medical tubing solutions for some of the most well-known names in the medical, pharmaceutical, personal care, household and industrial, and food and beverage industries. Tekni-Plex was founded in 1967 and is based in Wayne, Pennsylvania.

Buy -
Mergr

Product

Company

Legal